ASDAS states in patients stratified by baseline MRI/CRP status.

Disease Control Data, Ankylosing Spondylitis

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers - Liu - 2023 - Journal of Internal Medicine - Wiley Online Library

ASDAS-CRP (full analysis set). (A) Change in ASDAS-CRP score from

IJMS, Free Full-Text

Frontiers Adverse association of epicardial adipose tissue accumulation with cardiac function and atrioventricular coupling in postmenopausal women assessed by cardiac magnetic resonance imaging

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet

Immune targets for therapeutic development in depression: towards precision medicine

Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week - ScienceDirect

MRI and serum high-sensitivity C reactive protein predict long-term mortality in non-ischaemic cardiomyopathy – topic of research paper in Basic medicine. Download scholarly article PDF and read for free on CyberLeninka open

Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study - The Lancet Rheumatology

Cardio-Oncology Recommendations for Pediatric Oncology Patients: An Australian and New Zealand Delphi Consensus

PDF) Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial